Study of the anti-exudative activity of dry extract from Prunus Domestica fruits


  • I. V. Seniuk National University of Pharmacy, Ukraine
  • B. J. A. Sahlanee National University of Pharmacy, Ukraine



Prunus domestica fruits, zymosan-induced edema, exudation, prostaglandins, leukotrienes, hepatoprotectors


Topicality. Previous experimental studies of the pharmacological properties of extracts from Prunus domestica fruits revealed the most therapeutically active extract with fibers by laxative and hepatoprotective activities. The hepatoprotective activity of the dry extract from Prunus domestica fruits containing fibers is probably due to the presence of polyphenolic components in the chemical composition of the extract. Based on the analysis of the literature data for polyphenolic compounds, anti-exudative properties are characteristic; therefore, it was reasonable to study the effect of the investigated extract on the cyclooxygenase and lipoxygenase routes of the inflammatory reaction development.

Aim. To investigate experimentally the effect of dry extract from Prunus domestica fruits containing fibers on the development of the anti-exudative phase of inflammation.

Results and discussion. The pretreatment of the animals with extract from Prunus domestica fruits moderately suppressed the development of zymosan-induced edema in all studied periods. Indicators of anti-exudative activity of the studied extract (29.65 %) were lower than activity of reference drug quercetin (36.6 %) and were at the level of indicators of anti-flogogenic manifestations of the reference drug Silybor (29.5 %). The moderate anti-exudative activity of the investigated extract suggests that it suppresses the formation of leukotrienes in the early stages of the inflammatory reaction development (0.5 hours), and prostaglandins – after 3 hours.

Conclusions. Analysis of the experimental data showed a slight anti-cyclo-oxygenase and anti-lipooxygenase activity of the dry extract from Prunus domestica fruits containing fibers. The investigated extract was lower in its ability to inhibit the anti-cyclooxygenase and anti-lipooxygenase pathways of the development of the exudative phase of inflammation than the reference drug quercetin. The moderate anti-inflammatory effect of this extract is probably due to the presence of polyphenolic compounds in its chemical composition.

Author Biographies

I. V. Seniuk, National University of Pharmacy

Ph.D in Pharmacy, associate professor of the Department of Biological Chemistry

B. J. A. Sahlanee, National University of Pharmacy

Doctoral student of the Department of Biological Chemistry


Harnyk, T. P. (2008). Fitoterapiia. Chasopyc, 1, 59–63.

Zhou, Y., Li, Y., Zhou, T., Zheng, J., Li, S., & Li, H.-B. (2016). Dietary Natural Products for Prevention and Treatment of Liver Cancer. Nutrients, 8(3), 156.

Bose, M., Kamra, M., Mullick, R., Bhattacharya, S., Das, S., & Karande, A. A. (2017). Identification of a flavonoid isolated from plum (Prunus domestica) as a potent inhibitor of Hepatitis C virus entry. Scientific Reports, 7 (1).

Upyr, L. V. Slyva. (2010). Farmatsevtychna entsyklopediia (Edition II). Kyiv: «MORION», 1290.

Mohammed Shahm Basim, Lenchik L. V., Caidov N. B. (2017). Prunus Domestica fruits – perspective row for drugs development. Nauka i innovaciya. Seriya estestvennyh nauk, 4, 42–48.

Upyr, T., Basim Mohammed, S., Bashar, A.-J. A. S., Lenchyk, L., Senyuk, I., & Kyslychenko, V. (2018). Phytochemical and pharmacological study of polysaccharide complexes of prunus domestica fruit. ScienceRise: Pharmaceutical Science, 3 (13), 32–37.

Celik, F., Gundogdu, M., Alp, S., Muradoglu, F., Ercişli, S., Gecer, M. K., & Canan, I. (2017). Determination of phenolic compounds, antioxidant capacity and organic acids contents of Prunus domestica L., Prunus cerasifera Ehrh. and Prunus spinosa L. fruits by HPLC. Acta Chromatographica, 29(4), 507–510.

Senyuk, I. V., Bashar, A.-S. J., & Lenchyk, L. V. (2017). Investigation of different substances catharic properties made from Prunus domestica. Ukraïns’kij Bìofarmacevtičnij Žurnal, 5(52), 21–25.

Senyuk, I. V., Al Sahlani, B. J., & Basim, M. S. (2018). Farmatsevtychnyi Chasopys, 4, 57–61.

Drogovoz, S. M., Derimedved, S. V., Nikolenko, V. V. (1999). Fiziolohichno aktyvni rechovyny, 2 (28), 86–89.

Stefanov, O. V. (2001). Doklinichni doslidzhennia likarskykh zasobiv: Metodychni rekomendatsii. Kyiv: Avitsena, 528.

Gado, K., Gigler, G. (1991). Zymozan inflammation. A new method suitable for evaluating new anti-inflammatory drugs. Agents and Actions, 32(1-2), 119–121.





Pharmacology and biochemistry